[artículo] 
inJournal of the American Academy of Child & Adolescent Psychiatry > Año 2025 - Vol. 64 - No. 7 (July) . - pp. 768-769

Título :	Editorial: Meta-Analysis of Individual Participant Data From Trials of Selective Serotonin Reuptake Inhibitors for Pediatric Obsessive-Compulsive Disorder: A Gold Standard Approach.
Tipo de documento:	texto impreso
Fecha de publicación:	2026
Artículo en la página:	pp. 768-769
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Etiquetas:	Trastorno obsesivo-compulsivo -- tratamiento farmacológico, Inhibidores selectivos de la recaptación de serotonina -- uso terapéutico, Metaanálisis como tema -- Adolescentes,
Resumen:	Pediatric obsessive-compulsive disorder (OCD) is a common (2% prevalence) and potentially debilitating condition.1 Early identification and intervention are critical because they may improve outcomes for children and adolescents with OCD and prevent long-term morbidity. The individual participant data (IPD) meta-analysis by Cohen and colleagues2 explores the efficacy of short-term trials of selective serotonin reuptake inhibitors (SSRIs) compared to placebo for treating children and adolescents with OCD. It also investigates the moderating effects of baseline patient variables on treatment outcome.
Link:	./index.php?lvl=notice_display&id=31640

[artículo] Editorial: Meta-Analysis of Individual Participant Data From Trials of Selective Serotonin Reuptake Inhibitors for Pediatric Obsessive-Compulsive Disorder: A Gold Standard Approach. [texto impreso] . - 2026 . - pp. 768-769.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2025 - Vol. 64 - No. 7 (July) . - pp. 768-769

Etiquetas:	Trastorno obsesivo-compulsivo -- tratamiento farmacológico, Inhibidores selectivos de la recaptación de serotonina -- uso terapéutico, Metaanálisis como tema -- Adolescentes,
Resumen:	Pediatric obsessive-compulsive disorder (OCD) is a common (2% prevalence) and potentially debilitating condition.1 Early identification and intervention are critical because they may improve outcomes for children and adolescents with OCD and prevent long-term morbidity. The individual participant data (IPD) meta-analysis by Cohen and colleagues2 explores the efficacy of short-term trials of selective serotonin reuptake inhibitors (SSRIs) compared to placebo for treating children and adolescents with OCD. It also investigates the moderating effects of baseline patient variables on treatment outcome.
Link:	./index.php?lvl=notice_display&id=31640